Gene · 3568
Papers2,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,231
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New Insights into Biomarkers for Evaluating Therapy Efficacy in Pulmonary Tuberculosis: A Narrative Review. | Infect Dis Ther | 2023 | 37938418 | PubTator, text mining | PubMed |
| An Emerging Role of Extracellular Traps in Chronic Rhinosinusitis. | Curr Allergy Asthma Rep | 2023 | 37934391 | PubTator, text mining | PubMed |
| Risk assessment of cancer patients based on HLA-I alleles, neobinders and expression of cytokines. | Comput Biol Med | 2023 | 37918263 | PubTator, text mining | PubMed |
| Stepwise Approach in Asthma Revisited 2023: Expert Panel Opinion of Turkish Guideline of Asthma Diagnosis and Management Group. | Thorac Res Pract | 2023 | 37909830 | PubTator, text mining | PubMed |
| Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis. | ERJ Open Res | 2023 | 37908397 | PubTator, text mining | PubMed |
| The Study of the Influence of IL5RA Variants on Chronic Obstructive Pulmonary Disease. | COPD | 2023 | 37905709 | PubTator, text mining | PubMed |
| Real-world super-response to biologics in severe asthma: A French monocentric retrospective cohort study. | Respir Med Res | 2023 | 37897876 | PubTator, text mining | PubMed |
| Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases. | Int J Mol Sci | 2023 | 37894846 | PubTator, text mining | PubMed |
| Electrical Characterization and Analysis of Single Cells and Related Applications. | Biosensors (Basel) | 2023 | 37887100 | PubTator, text mining | PubMed |
| IgE Immune Complexes Mitigate Eosinophilic Immune Responses through NLRC4 Inflammasome. | Mediators Inflamm | 2023 | 37885469 | PubTator, text mining | PubMed |
| Development and characterization of anti-IL-5 monoclonal antibody Fab fragment for blocking IL-5/IL-5Rα binding. | Int Immunopharmacol | 2023 | 37832239 | PubTator, text mining | PubMed |
| Integration of exome-seq and mRNA-seq using DawnRank, identified genes involved in innate immunity as drivers of breast cancer in the Indian cohort. | PeerJ | 2023 | 37810779 | PubTator, text mining | PubMed |
| Eosinophil trafficking in allergen-mediated pulmonary inflammation relies on IL-13-driven CCL-11 and CCL-24 production by tissue fibroblasts and myeloid cells. | J Allergy Clin Immunol Glob | 2023 | 37781651 | PubTator, text mining | PubMed |
| Macroarray expression analysis of cytokines and prostaglandin metabolism-related genes in chronic rhinosinusitis. | J Allergy Clin Immunol Glob | 2023 | 37779524 | PubTator, text mining | PubMed |
| Screening and identifying of biomarkers in early colorectal cancer and adenoma based on genome-wide methylation profiles. | World J Surg Oncol | 2023 | 37779184 | PubTator, text mining | PubMed |
| Does NSAID exacerbated respiratory disease (N-ERD) accompanying severe asthma affect biological treatment response? Efficacy of omalizumab and mepolizumab in N-ERD. | World Allergy Organ J | 2023 | 37771938 | PubTator, text mining | PubMed |
| Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study. | Respir Res | 2023 | 37770889 | PubTator, text mining | PubMed |
| Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target Therapy. | Pharmaceutics | 2023 | 37765327 | PubTator, text mining | PubMed |
| Therapeutic Antibodies in Medicine. | Molecules | 2023 | 37764213 | PubTator, text mining | PubMed |
| Severe Asthma and Biological Therapies: Now and the Future. | J Clin Med | 2023 | 37762787 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3568/papers?page=14